Literature DB >> 32852839

Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria.

Brigida Barberio1, Sanjiv Mahadeva2, Christopher J Black3,4, Edoardo V Savarino1, Alexander C Ford3,4.   

Abstract

BACKGROUND: Prevalence of uninvestigated dyspepsia varies across cross-sectional surveys. This may be due to differences in definitions used or study methodology, rather than global variability. AIM: To determine the global prevalence of uninvestigated dyspepsia according to Rome criteria.
METHODS: MEDLINE and EMBASE were searched to identify population-based studies reporting prevalence of uninvestigated dyspepsia in adults (≥18 years old) according to Rome I, II, III or IV criteria. Prevalence of uninvestigated dyspepsia was extracted, according to criteria used to define it. Pooled prevalence, according to study location and certain other characteristics, odds ratios (OR), and 95% confidence intervals (CIs) were calculated.
RESULTS: Of 2133 citations evaluated, 67 studies fulfilled eligibility criteria, representing 98 separate populations, comprising 338 383 subjects. Pooled prevalence ranged from 17.6% (95% CI 9.8%-27.1%) in studies defining uninvestigated dyspepsia according to Rome I criteria, to 6.9% (95% CI 5.7%-8.2%) in those using Rome IV criteria. Postprandial distress syndrome was the commonest subtype, occurring in 46.2% of participants using Rome III criteria, and 62.8% with Rome IV. Prevalence of uninvestigated dyspepsia was up to 1.5-fold higher in women, irrespective of the definition used. There was significant heterogeneity between studies in all our analyses, which persisted even when the same criteria were applied and similar methodology was used.
CONCLUSIONS: Even when uniform symptom-based criteria are used to define the presence of uninvestigated dyspepsia, prevalence varies between countries. This suggests that there are environmental, cultural, ethnic, dietary or genetic influences determining symptoms.
© 2020 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32852839     DOI: 10.1111/apt.16006

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  History-taking, Clinical Signs, Tests and Scores for Detection of Non-organic Dyspepsia (NOD) Among Patients With Acute Abdominal Pain (AAP).

Authors:  Maaret Eskelinen; Jannica Meklin; Tuomas Selander; Kari Syrjänen; Matti Eskelinen
Journal:  Cancer Diagn Progn       Date:  2021-07-03

2.  British Society of Gastroenterology guidelines on the management of functional dyspepsia.

Authors:  Christopher J Black; Peter A Paine; Anurag Agrawal; Imran Aziz; Maria P Eugenicos; Lesley A Houghton; Pali Hungin; Ross Overshott; Dipesh H Vasant; Sheryl Rudd; Richard C Winning; Maura Corsetti; Alexander C Ford
Journal:  Gut       Date:  2022-07-07       Impact factor: 31.793

3.  Predicting acupuncture efficacy for functional dyspepsia based on routine clinical features: a machine learning study in the framework of predictive, preventive, and personalized medicine.

Authors:  Tao Yin; Hui Zheng; Tingting Ma; Xiaoping Tian; Jing Xu; Ying Li; Lei Lan; Mailan Liu; Ruirui Sun; Yong Tang; Fanrong Liang; Fang Zeng
Journal:  EPMA J       Date:  2022-02-02       Impact factor: 6.543

4.  Prevalence and trigger factors of functional gastrointestinal disorders among male civil pilots in China.

Authors:  Chen Li; Junrong Xu; Daiwen Yin; Yuhai Zhang; Dezhi Shan; Xun Jiang; Lei Shang
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

5.  Efficacy evaluation of acupuncture combined with Liujunzi Decoction in the treatment of functional dyspepsia: A protocol of randomized controlled trial.

Authors:  Yulan Zhang; Lihong Bian; Huan Long; Weichen Zhang; Yuqiong Hu
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

6.  Diagnostic Challenges of Helicobacter pylori Infection in Ethiopia: A Community-Based Cross-Sectional Study.

Authors:  Esayas Kebede Gudina; Hiwot Amare; Solomon Ali; Melkamu Berhane Arefayine; Dagmawi Tewolde; Million Tesfaye Eshete; Mulusew Gerbaba Jebena; Andreas Wieser; Guenter Froeschl; Markos Tesfaye; Hailemichael Desalegn; Mulatu Gashaw
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.